Which two anticoagulants require special precautions during physical therapy due to increased bleeding risk?

Which two anticoagulants require special precautions during physical therapy due to increased bleeding risk?

• A. Warfarin and direct oral anticoagulants (DOACs)
• B. Heparin and Warfarin
• C. Aspirin and DOACs
• D. Enoxaparin and Aspirin

Answer: (A)

Anticoagulants raise the risk of bleeding, so physical therapy must be careful to minimize tissue trauma and monitor for signs of bleeding. Warfarin and direct oral anticoagulants are notable because they provide systemic anticoagulation with different monitoring approaches. Warfarin’s effect is tracked with the INR, and doses are adjusted to keep the INR in a therapeutic range. Even within that range, the risk of bleeding remains and can be influenced by diet, other meds, or acute illness, so therapy planning centers on avoiding high-risk manual techniques, scheduling around dosing, and communicating with the prescriber about current INR. Direct oral anticoagulants work differently: they inhibit specific clotting factors to create a predictable anticoagulant effect and typically don’t require routine lab monitoring. However, their bleeding risk is still real, and there may be limited reversible options or delays in stopping the effect if a bleed occurs. In PT sessions, this means gentler interventions, careful assessment of bleeding signs, and coordinating with the medical team about timing of doses and any necessary precautions. Other meds like aspirin also affect bleeding but are antiplatelet rather than full anticoagulation, so the level of precaution differs. The combination of warfarin or DOACs represents the scenario where bleeding risk is a central and ongoing consideration for planning and performing physical therapy.

Anticoagulants raise the risk of bleeding, so physical therapy must be careful to minimize tissue trauma and monitor for signs of bleeding. Warfarin and direct oral anticoagulants are notable because they provide systemic anticoagulation with different monitoring approaches. Warfarin’s effect is tracked with the INR, and doses are adjusted to keep the INR in a therapeutic range. Even within that range, the risk of bleeding remains and can be influenced by diet, other meds, or acute illness, so therapy planning centers on avoiding high-risk manual techniques, scheduling around dosing, and communicating with the prescriber about current INR.

Direct oral anticoagulants work differently: they inhibit specific clotting factors to create a predictable anticoagulant effect and typically don’t require routine lab monitoring. However, their bleeding risk is still real, and there may be limited reversible options or delays in stopping the effect if a bleed occurs. In PT sessions, this means gentler interventions, careful assessment of bleeding signs, and coordinating with the medical team about timing of doses and any necessary precautions.

Other meds like aspirin also affect bleeding but are antiplatelet rather than full anticoagulation, so the level of precaution differs. The combination of warfarin or DOACs represents the scenario where bleeding risk is a central and ongoing consideration for planning and performing physical therapy.